Insights

ISF Platform KIFFIK focuses on interstitial fluid ISF-based diagnostics and continuous molecular insight, presenting a recurring opportunity to engage pharma and diagnostics teams seeking non-invasive biomarker access and longitudinal data for drug development and companion diagnostics.

Strategic Partnerships Recent and ongoing partnerships with Beacon MedTech and HekaBio K.K. indicate a momentum in manufacturing and regional expansion, suggesting sales potential through collaboration with device manufacturers and APAC partners to scale platform access.

Executive Growth New appointments of a Chief Technology Officer and Chief Scientific Officer signal leadership expansion and technical maturity, creating openings for enterprise collaborations, pilot programs, and co-development opportunities with CROs and pharma researchers.

Late 2026 Launch Upcoming K-EXP platform deployment for select clinical partners by late 2026 presents a near-term selling window to secure pilot programs, data-sharing agreements, and early access deals with pharmaceutical and diagnostic developers.

Global Reach Strategic alliances to extend ISF access across Japan and Asia-Pacific indicate a pathway to multi-region deployments, offering opportunities to tailor regional trials, regulatory-ready studies, and real-world evidence generation for global sponsors.

Similar companies to Kiffik Biomedical, Inc.

Kiffik Biomedical, Inc. Tech Stack

Kiffik Biomedical, Inc. uses 8 technology products and services including HubSpot Analytics, Amazon Web Services, WordPress, and more. Explore Kiffik Biomedical, Inc.'s tech stack below.

Media & News

Kiffik Biomedical, Inc.'s Email Address Formats

Kiffik Biomedical, Inc. uses at least 2 email formats:
Kiffik Biomedical, Inc. Email FormatsExamplePercentage
First.Last@kiffik.comJohn.Doe@kiffik.com
89%
F.Last@kiffik.comJ.Doe@kiffik.com
11%

Frequently Asked Questions

What is Kiffik Biomedical, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Kiffik Biomedical, Inc.'s official website is kiffik.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Kiffik Biomedical, Inc. generate?

Minus sign iconPlus sign icon
As of July 2026, Kiffik Biomedical, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Kiffik Biomedical, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Kiffik Biomedical, Inc.'s NAICS code is 6215 - Medical and Diagnostic Laboratories.

How many employees does Kiffik Biomedical, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Kiffik Biomedical, Inc. has approximately 19 employees across 2 continents, including North America and Europe. Key team members include Chief Commercial Officer: E. D., Chief Strategy Officer: J. F. and Chief Scientific Officer: A. E. Explore Kiffik Biomedical, Inc.'s employee directory with LeadIQ.

What industry does Kiffik Biomedical, Inc. belong to?

Minus sign iconPlus sign icon
Kiffik Biomedical, Inc. operates in the Medical and Diagnostic Laboratories industry.

What technology does Kiffik Biomedical, Inc. use?

Minus sign iconPlus sign icon
Kiffik Biomedical, Inc.'s tech stack includes HubSpot Analytics, Amazon Web Services, WordPress, Microsoft 365, Google Cloud, Netlify, WP Engine and Vimeo.

What is Kiffik Biomedical, Inc.'s email format?

Minus sign iconPlus sign icon
Kiffik Biomedical, Inc.'s email format typically follows the pattern of First.Last@kiffik.com. Find more Kiffik Biomedical, Inc. email formats with LeadIQ.

How much funding has Kiffik Biomedical, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Kiffik Biomedical, Inc. has raised $2.2M in funding. The last funding round occurred on Dec 17, 2025 for $830K.

When was Kiffik Biomedical, Inc. founded?

Minus sign iconPlus sign icon
Kiffik Biomedical, Inc. was founded in 2021.
Kiffik Biomedical, Inc. logo

Kiffik Biomedical, Inc.

Medical and Diagnostic LaboratoriesFlorida, United States11-50 Employees

Kiffik Biomedical, Inc. operates in the medical and diagnostic laboratory sector, developing an infrastructure platform that provides continuous, tissue-level molecular insight. Its K-EXP platform aims to move beyond episodic testing toward longitudinal understanding of biology, supporting collaboration with pharmaceutical, diagnostics, and healthcare leaders to accelerate drug development, improve clinical trial efficiency, enable next-generation companion diagnostics, and generate real-world evidence that reflects biology in action. The company positions itself as scalable infrastructure capable of encompassing multiple biomarkers, indications, and partner ecosystems rather than a single test or device.
Based in Miami, Florida, KIFFIK serves a varied customer base within biopharma and healthcare, focusing on teams that require earlier visibility into biological changes to inform decision-making. Recent strategic activities include partnerships and leadership appointments aimed at expanding access to interstitial fluid–based diagnostics and to advancing its platform across international markets. The organization emphasizes a goal of providing earlier, clearer molecular insight to support better, data-driven decisions in drug development and diagnostics.

Section iconCompany Overview

Website
kiffik.com
NAICS Code
6215 - Medical and Diagnostic Laboratories
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $2.2M

    Kiffik Biomedical, Inc. has raised a total of $2.2M of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2025 in the amount of $830K as a Series A.

  • $1M - $10M

    Kiffik Biomedical, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.